Ruan DT - Search Results

1

Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma.

Lin CI, Whang EE, Moalem J, Ruan DT. Lin CI, et al. Among authors: ruan dt. Surgery. 2012 Dec;152(6):1045-50. doi: 10.1016/j.surg.2012.08.035. Epub 2012 Oct 25. Surgery. 2012. PMID: 23102636

2

Autophagy: a new target for advanced papillary thyroid cancer therapy.

Lin CI, Whang EE, Abramson MA, Jiang X, Price BD, Donner DB, Moore FD Jr, Ruan DT. Lin CI, et al. Among authors: ruan dt. Surgery. 2009 Dec;146(6):1208-14. doi: 10.1016/j.surg.2009.09.019. Surgery. 2009. PMID: 19958950

3

Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.

Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore FD Jr, Ruan DT. Nehs MA, et al. Among authors: ruan dt. Surgery. 2011 Dec;150(6):1032-9. doi: 10.1016/j.surg.2011.09.012. Surgery. 2011. PMID: 22136818

4

Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.

Lin CI, Barletta JA, Nehs MA, Morris ZS, Donner DB, Whang EE, Jeong JW, Kimura S, Moore FD Jr, Ruan DT. Lin CI, et al. Among authors: ruan dt. Surgery. 2011 Dec;150(6):1295-302. doi: 10.1016/j.surg.2011.09.014. Surgery. 2011. PMID: 22136853 Free PMC article.

5

Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.

Cho NL, Lin CI, Du J, Whang EE, Ito H, Moore FD Jr, Ruan DT. Cho NL, et al. Among authors: ruan dt. Biochem Biophys Res Commun. 2012 May 11;421(3):508-13. doi: 10.1016/j.bbrc.2012.04.034. Epub 2012 Apr 10. Biochem Biophys Res Commun. 2012. PMID: 22521882

6

Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer.

Lin CI, Whang EE, Lorch JH, Ruan DT. Lin CI, et al. Among authors: ruan dt. Surgery. 2012 Dec;152(6):1142-9. doi: 10.1016/j.surg.2012.08.016. Surgery. 2012. PMID: 23158184

7

Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.

Lin CI, Whang EE, Abramson MA, Donner DB, Bertagnolli MM, Moore FD Jr, Ruan DT. Lin CI, et al. Among authors: ruan dt. Biochem Biophys Res Commun. 2009 Feb 6;379(2):626-31. doi: 10.1016/j.bbrc.2008.12.153. Epub 2009 Jan 3. Biochem Biophys Res Commun. 2009. PMID: 19124005

8

Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.

Lin CI, Whang EE, Donner DB, Jiang X, Price BD, Carothers AM, Delaine T, Leffler H, Nilsson UJ, Nose V, Moore FD Jr, Ruan DT. Lin CI, et al. Among authors: ruan dt. Mol Cancer Res. 2009 Oct;7(10):1655-62. doi: 10.1158/1541-7786.MCR-09-0274. Epub 2009 Oct 13. Mol Cancer Res. 2009. PMID: 19825987 Free article.

9

Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.

Ito H, Abramson M, Ito K, Swanson E, Cho N, Ruan DT, Swanson RS, Whang EE. Ito H, et al. Among authors: ruan dt. J Gastrointest Surg. 2010 May;14(5):891-8. doi: 10.1007/s11605-010-1173-3. Epub 2010 Mar 12. J Gastrointest Surg. 2010. PMID: 20224984

10

Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.

Cho NL, Lin CI, Whang EE, Carothers AM, Moore FD Jr, Ruan DT. Cho NL, et al. Among authors: ruan dt. Thyroid. 2010 Jun;20(6):615-22. doi: 10.1089/thy.2009.0415. Thyroid. 2010. PMID: 20470206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters